Il-Hoon Jung

923 total citations
13 papers, 785 citations indexed

About

Il-Hoon Jung is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Il-Hoon Jung has authored 13 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Il-Hoon Jung's work include Ginseng Biological Effects and Applications (7 papers), Pharmacological Effects of Natural Compounds (4 papers) and Diabetes Treatment and Management (3 papers). Il-Hoon Jung is often cited by papers focused on Ginseng Biological Effects and Applications (7 papers), Pharmacological Effects of Natural Compounds (4 papers) and Diabetes Treatment and Management (3 papers). Il-Hoon Jung collaborates with scholars based in South Korea. Il-Hoon Jung's co-authors include Dong‐Hyun Kim, Eun‐Ha Joh, In‐Ah Lee, Thi Kim Van Le, In Sook Kim, Hye Hyun Yoo, Jin-Ju Jeong, Donghyun Kim, Eun‐jin Kim and Nam‐Jae Kim and has published in prestigious journals such as PLoS ONE, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Il-Hoon Jung

13 papers receiving 765 citations

Peers

Il-Hoon Jung
Yun Hee Jeong South Korea
Ming Lyu China
Sungwon Lee South Korea
Thi Kim Van Le South Korea
Gefu Chi China
Ou Shuai China
Il-Hoon Jung
Citations per year, relative to Il-Hoon Jung Il-Hoon Jung (= 1×) peers Zezheng Gao

Countries citing papers authored by Il-Hoon Jung

Since Specialization
Citations

This map shows the geographic impact of Il-Hoon Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Il-Hoon Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Il-Hoon Jung more than expected).

Fields of papers citing papers by Il-Hoon Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Il-Hoon Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Il-Hoon Jung. The network helps show where Il-Hoon Jung may publish in the future.

Co-authorship network of co-authors of Il-Hoon Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Il-Hoon Jung. A scholar is included among the top collaborators of Il-Hoon Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Il-Hoon Jung. Il-Hoon Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lee, Bo Ram, et al.. (2023). GPR119 activation by DA-1241 alleviates hepatic and systemic inflammation in MASH mice through inhibition of NFκB signaling. Biomedicine & Pharmacotherapy. 166. 115345–115345. 4 indexed citations
2.
Kim, Tae‐Hyoung, et al.. (2018). Additive effects of evogliptin in combination with pioglitazone on fasting glucose control through direct and indirect hepatic effects in diabetic mice. European Journal of Pharmacology. 830. 95–104. 4 indexed citations
3.
Kim, In Sook, Il-Hoon Jung, Su-Min Lim, et al.. (2016). Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirin. Biochemical Pharmacology. 122. 72–79. 67 indexed citations
4.
5.
Kim, Tae‐Hyoung, Mi Kyung Kim, Youngyi Lee, et al.. (2015). Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes. European Journal of Pharmacology. 771. 65–76. 19 indexed citations
6.
Kim, In Sook, et al.. (2014). Gut Microbiota-Mediated Drug Interactions between Lovastatin and Antibiotics. Drug Metabolism and Disposition. 42(9). 1508–1513. 118 indexed citations
7.
Kim, Eun‐jin, Il-Hoon Jung, Thi Kim Van Le, et al.. (2013). Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice. Journal of Ethnopharmacology. 146(1). 294–299. 106 indexed citations
8.
Kim, Kyung‐Ah, et al.. (2013). Comparative Analysis of the Gut Microbiota in People with Different Levels of Ginsenoside Rb1 Degradation to Compound K. PLoS ONE. 8(4). e62409–e62409. 95 indexed citations
9.
Jung, Il-Hoon, Se‐Eun Jang, Eun‐Ha Joh, et al.. (2012). Lancemaside A isolated from Codonopsis lanceolata and its metabolite echinocystic acid ameliorate scopolamine-induced memory and learning deficits in mice. Phytomedicine. 20(1). 84–88. 45 indexed citations
10.
Hyun, Yang-Jin, Il-Hoon Jung, & Dong‐Hyun Kim. (2012). Expression of heparinase I of Bacteroides stercoris HJ-15 and its degradation tendency toward heparin-like glycosaminoglycans. Carbohydrate Research. 359. 37–43. 9 indexed citations
11.
Jang, Se‐Eun, Il-Hoon Jung, Eun‐Ha Joh, Myung Joo Han, & Dong‐Hyun Kim. (2012). Antibiotics attenuate anti-scratching behavioral effect of ginsenoside Re in mice. Journal of Ethnopharmacology. 142(1). 105–112. 14 indexed citations
12.
Jung, Il-Hoon, Jeong Hoon Lee, Yang-Jin Hyun, & Dong‐Hyun Kim. (2012). Metabolism of Ginsenoside Rb1 by Human Intestinal Microflora and Cloning of Its Metabolizing β-<small>D</small>-Glucosidase from <i>Bifidobacterium longum</i> H-1. Biological and Pharmaceutical Bulletin. 35(4). 573–581. 47 indexed citations
13.
Joh, Eun‐Ha, In‐Ah Lee, Il-Hoon Jung, & Dong‐Hyun Kim. (2011). Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation—The key step of inflammation. Biochemical Pharmacology. 82(3). 278–286. 224 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026